Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > NDA approval

<< Previous

Bullboard Posts

Next >>

Comment by subaru1on May 28, 2024 10:06am

93 Views

Post# 36060165

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NDA approval

Okgonow there has millions traded at $0,06 and $0,065 at $0,08 and $0,85 it is easy money done on a sleeper and there is these other guy that have eneough of waiting and they give up at $0,08 and i wouldn't be surprise to see $0,07 to come if we don't get any news in the coming month. The reschedule from 1 to 3 is not for tomorrow not before october, so if MPL still keep all these supposed good things secret for them we will hit $0,07 before the 2qrt is released in mid august, that it is still a long wait and even by then if they break even we won't move that much unless they have a fantastic surprise for us like a $14 millions revenue

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record